David Nakasone
Investor Relations Contact chez TARSUS PHARMACEUTICALS, INC.
Profil
David Nakasone is currently a Senior Director of Investor Relations at Tarsus Pharmaceuticals, Inc. Prior to this, he worked as a Director of Investor Relations at Lineage Cell Therapeutics, Inc. and as an Associate Director of Investor Relations at Ionis Pharmaceuticals, Inc. He also served as an Investor Relations Contact at Allergan, Inc. from 2013 to 2015.
Mr. Nakasone received his undergraduate degree from San Diego State University.
Postes actifs de David Nakasone
| Sociétés | Poste | Début |
|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Anciens postes connus de David Nakasone
| Sociétés | Poste | Fin |
|---|---|---|
| ALLERGAN, INC. | Public Communications Contact | 01/06/2015 |
| IONIS PHARMACEUTICALS, INC. | Public Communications Contact | - |
| LINEAGE CELL THERAPEUTICS, INC. | Investor Relations Contact | - |
Formation de David Nakasone
| San Diego State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| TARSUS PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
